Trial intelligence / Profile preview

Fluoxetine for Motor Recovery After Stroke

NCT02063425Terminated

Sponsor
Centre Hospitalier Sainte-Anne
Start
Feb 2014
Primary completion
Aug 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in ischemic stroke comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Slope of the curve of recruitment of the PEMs at 3 months. Started Feb 2014; status: terminated.

02

Drugs

fluoxetine
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT02063425.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02063425.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call